News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Biogen Idec, Inc. (Massachusetts) To Spend Big On Acquisitions
February 23, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Biogen Idec Inc. (BIIB.O: Quote, Profile, Research) is ready, willing and able to spend billions of dollars to acquire new drugs to help fuel double digit returns over the next five years.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Biogen
MORE ON THIS TOPIC
Mergers & acquisitions
Revolution Soars Amid Swirling Buyout Rumors With Merck, AbbVie
January 9, 2026
·
1 min read
·
Tristan Manalac
Insights
From Nuclear Winter to Renewal: Biotech Investing for 2026
January 8, 2026
·
1 min read
·
Jennifer Smith-Parker
Collaboration
Lilly Bulks Up Inflammatory Pipeline With $1.2B Ventyx Buy, InduPro Cancer Pact
January 8, 2026
·
2 min read
·
Tristan Manalac
Layoffs
Biopharmas Axed 47% More Employees Year Over Year
January 8, 2026
·
5 min read
·
Angela Gabriel